Balaxi Pharmaceuticals Ltd

About

Balaxi Ventures is a pharma company. Majority of its sales comes from Africa, Caribbean Islands & Latin America. It is headquartered in Hyderabad. [1]

Key Points

Angola and Carribiean
The company has a "stock and sell" model in three different geographies: Angola in Africa and Dominican Republic and Guatemala in Latin America [1]. Company has 548 product registrations of which 289 are in Angola, 79 in Guatemala and 136 in Dominican Republic [2]. The subsidiaries in Guatemala and Dominican Republic were recently acquired [2].

See full details
  • Market Cap 574 Cr.
  • Current Price 574
  • High / Low 1,080 / 500
  • Stock P/E 14.3
  • Book Value 65.0
  • Dividend Yield 0.00 %
  • ROCE 92.6 %
  • ROE 82.3 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter
  • Debtor days have improved from 168.52 to 121.11 days.

Cons

  • Stock is trading at 8.83 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Tax rate seems low

Peer comparison

Sector: Trading Industry: Trading

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
6 8 13 13 12 52 60 66 53 58
5 7 12 10 10 43 50 54 43 47
Operating Profit 1 1 1 3 2 9 10 12 10 11
OPM % 11% 18% 8% 21% 15% 17% 17% 18% 19% 20%
Other Income 0 -0 1 1 1 2 2 0 -0 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Profit before tax 1 1 2 3 2 10 12 12 10 12
Tax % 41% 28% 28% 29% 39% 17% 14% 10% 16% 14%
Net Profit 1 1 1 2 1 9 10 11 8 11
EPS in Rs 2.27 3.39 1.14 2.47 1.46 8.70 10.12 10.95 8.36 10.71

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 TTM
14 46 231 238
12 37 189 194
Operating Profit 2 8 43 44
OPM % 11% 18% 18% 18%
Other Income 1 1 2 3
Interest 0 0 0 0
Depreciation 0 0 0 0
Profit before tax 2 9 44 46
Tax % 19% 31% 14%
Net Profit 2 6 38 40
EPS in Rs 6.48 6.10 38.14 40.14
Dividend Payout % 0% 0% 0%
Compounded Sales Growth
10 Years:%
5 Years:%
3 Years:%
TTM:166%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:192%
Stock Price CAGR
10 Years:%
5 Years:100%
3 Years:168%
1 Year:-23%
Return on Equity
10 Years:%
5 Years:%
3 Years:%
Last Year:82%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021
3 10 10
Reserves 0 18 55
Borrowings 0 0 4
3 8 31
Total Liabilities 6 36 100
0 0 2
CWIP 0 0 0
Investments 0 0 3
6 36 94
Total Assets 6 36 100

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021
-2 -14 0
-0 -0 -6
0 18 4
Net Cash Flow -2 4 -2

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021
Debtor Days 147 238 121
Inventory Days 9 29
Days Payable 64 53
Cash Conversion Cycle 147 183 97
Working Capital Days 82 181 96
ROCE % 57% 93%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents